Agoracom Blog

Choosing Faith Over Fear. Not Religion. Faith

Posted by AGORACOM at 6:18 PM on Friday, November 14th, 2014
“I can tell you from experience, the affect you have on others is the most valuable currency there is; Because everything you gain in life will rot and fall apart and all that will be left of you, is what was in your heart” –Jim Carrey
“I don’t believe in hope.  Hope is a beggar”

Xylitol Canada Announces 60% Revenue Growth for the Nine Months Ended Sept 30, 2014

Posted by AGORACOM-JC at 4:49 PM on Friday, November 14th, 2014

TORONTO, ONTARIO–(Nov. 14, 2014) - Xylitol Canada Inc. (“Xylitol Canada“, or the “Company“) (TSX VENTURE:XYL) today announces that it has released its financial and operating results for the Fiscal 3rd Quarter and nine months ending September 30, 2014. Highlights of the results include:

“We are pleased that the commercial acceptance for our products continues to be at an all-time high as indicated by our 60% year over year revenue growth. The strong U.S. Dollar combined with geographic sales mix led to some margin compression during the quarter. Our product division intends to implement measures in Q4 to enhance gross margins as we enter our busiest season. We look forward to continued expansion of our product division as the negative pressure on refined sugar and artificial sweeteners continue to accelerate,” commented Andrew Reid, CEO of Xylitol Canada.

The Company also wishes to thank Frank Iadipaolo for his services as interim CFO during the 2nd and 3rd quarters of 2014. Mr. Iadipaolo was instrumental in setting up a robust internal control system, daily and weekly divisional reporting, and he architected an across the board costing and margin analysis program. Mr. Iadipaolo’s structural initiatives under a tight timeline are applauded. During this transition, the Company would like to welcome Kyle Appleby back to Xylitol Canada as CFO.

The full text of the Company’s interim consolidated financial statements and related management’s discussion and analysis (“MD&A”) can be found at: www.sedar.com.

About Xylitol Canada Inc.

Xylitol Canada markets xylitol and xylitol based-products and is focused on becoming a major low-cost manufacturer of xylitol and related products, serving the global market from operations in North America. Xylitol Canada’s business strategy is to leverage novel proprietary technology and processes to become North America’s premier manufacturer of low cost, high quality xylitol from readily available environmentally-sustainable biomass. Xylitol is a natural sweetener which is marketed globally including Canada and the United States and is accepted by the American Food and Drug Administration, the World Health Organization and the American Dental Association. Xylitol contains 75% less carbohydrates and 40% less calories than sugar, has a myriad of oral health benefits including the prevention of tooth decay and is safe for diabetics. To date, wider spread use of xylitol has been limited by the lack of a reliable, low cost, high quality supplier.

Neither TSX Venture Exchange Inc. nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

1-866-995-9952
IR@xylitolusa.com

KWG Files Amended and Restated Preliminary Short Form Prospectus for Equity Offering

Posted by AGORACOM-JC at 1:01 PM on Friday, November 14th, 2014

TORONTO, ONTARIO–(Nov. 14, 2014) - KWG Resources Inc. (“KWG” or the “Corporation“) (TSX VENTURE:KWG)(FRANKFURT:KW6) is pleased to announce that it has filed an amended and restated preliminary short form prospectus (the “Amended Prospectus“), which amends the preliminary short form prospectus filed by the Corporation on August 15, 2014. The Corporation has obtained a receipt from the securities regulatory authorities in the provinces of British Columbia, Ontario and Quebec in connection with a marketed offering (the “Offering“) of Units (as defined below) and Flow-Through Shares (as defined below) to be made in the provinces of British Columbia and Ontario. The Proposed Prospectus amends the proposed pricing of the Units, the proposed number of Units to be issued, the proposed pricing of the Flow-Through Shares and the number of Flow-Through Shares to be issued.

As previously disclosed in the Corporation’s press release dated August 18, 2014, the Corporation is targeting to raise minimum aggregate gross proceeds of $4 million (the “Minimum Offering“) and maximum aggregate gross proceeds of $10 million. The net proceeds of the Offering will be used to: (1) continue the development and commercialization of the new methods of production of chromium iron alloys from chromite ore and of production of low carbon chromium iron alloys (the “New Production Methods“); (2) conduct a drilling program at the Fishtrap Lake project; (3) continue the Corporation’s exploration program at the Koper Lake project; and (4) augment the Corporation’s working capital.

Secutor Capital Management Corporation (the “Agent“) has been appointed as exclusive lead agent for the Offering. The Corporation and the Agent have not yet entered into an agency agreement.

Each unit (a “Unit“) is comprised of three non “flow-through” common shares of KWG (each an “Offered Common Share“) and two non “flow-through” common share purchase warrants (each an “Offered Warrant“) at a price of $0.15 per Unit (the “Unit Offering Price“). Each Offered Warrant will entitle the holder to purchase one non “flow-through” common share of KWG (a “Warrant Share“) until the date that is 24 months following the closing of the Offering at a price of $0.10 per Warrant Share.

In addition, the Offering includes common shares of KWG, which will each qualify as a “flow-through share” (each, a “Flow-Through Share“) within the meaning of the Income Tax Act (Canada) at a price of $0.05 per Flow-Through Share (the “Flow-Through Offering Price“).

In connection with the Offering, the Corporation will grant to the Agent an option (the “Over-Allotment Option“) to sell, as agent, additional Flow-Through Shares (the “Additional Flow-Through Shares“), equal to not more than 15% of the number of Flow-Through Shares sold pursuant to the Maximum Offering, at the Flow-Through Offering Price and to purchase additional Units (the “Additional Units“), equal to not more than 15% of the number of Units sold pursuant to the Maximum Offering, at the Unit Offering Price to cover over-allotments, if any, and for market stabilization purposes. The Over-Allotment Option in respect of the Additional Flow-Through Shares will expire concurrently with the closing of the Offering. The Over-Allotment Option in respect of the Additional Units may be exercised at any time up to 30 days following the closing of the Offering.

Closing of the Offering is subject to certain conditions including, but not limited to, achievement of the Minimum Offering, the execution of a definitive agency agreement between the Corporation and the Agent and the receipt of all necessary approvals, including the approval of the applicable securities regulatory authorities and the TSX Venture Exchange.

The Amended Prospectus is still subject to completion or amendment. A copy of the Amended Prospectus will be available electronically at www.sedar.com. There will not be any sale of or any acceptance of an offer to buy the securities until a receipt for the (final) prospectus has been issued. The material set forth herein is for informational purposes only and does not constitute an offer of securities for sale in the United States or any other jurisdiction in which such an offer or solicitation is unlawful. The securities referred to herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the “Securities Act“), or the laws of any state, and may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state laws. No public offering of securities will be made in the United States.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding ForwardLooking Statements: This Press Release contains or refers to “forward-looking information” within the meaning of applicable Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects”, “is expected”, “budget”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might”, “occur” or “be achieved”. All information, other than information regarding historical fact that addresses activities, events or developments that KWG believes, expects or anticipates will or may occur in the future is forward-looking information. Forward-looking information contained in this Press Release is subject to a number of risks and uncertainties that may cause the actual results of KWG to differ materially from those discussed in the forward-looking information, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, KWG.
Should one or more of these risks and uncertainties occur, such as: the actual results of current exploration programs; risks normally incidental to exploration and development of mineral properties; the uncertainty of mineral resources estimates; uncertainties in the interpretation of drill results; the possibility that future exploration, development or mining results will not be consistent with expectations; the grade and recovery of ore varying from estimates; the general risks associated with the mining industry; the Corporation’s inability to maintain its title to its assets; the Corporation’s inability to obtain, maintain, renew and/or extend required licenses, permits, authorizations and/or approvals from the appropriate regulatory authorities and other risks relating to the applicable regulatory framework; environmental damages and the cost of compliance with environmental regulations; environmental risks; adverse land claims from First Nations groups or other parties; lack of adequate infrastructure; a lack of support from the Ontario government and federal government for the development of the Ring of Fire area; the patents to be used to support the commercialization of the New Production Methods will not be granted; capital and operating costs varying significantly from estimates; slowing demand for ferrochrome products; adverse general market conditions; inflation; changes in exchange and interest rates; adverse changes in commodity prices; the impact of consolidation and rationalization in the steel industry; competition; risk that amendments to current laws, regulations and permits governing operations and activities of mining companies will have a material adverse impact the Corporation; the risk that the New Production Methods does not prove efficient or economical; intellectual property litigation; risks related to the tax treatment of the Flow-Through Shares; and, management’s discretion as to use of proceeds, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, or expected. KWG does not intend and do not assume any obligation to update these forward
looking statements, except as required by law. Readers are cautioned not to put undue reliance on such forwardlooking statements.

Shares issued and outstanding: 777,842,468

KWG Resources Inc.
Bruce Hodgman
Vice-President
416-642-3575
info@kwgresources.com

Secutor Capital Management Corporation
Arie Papernick
(416) 847-1220

Neah Power Systems – Q&A Session Vol. 5 – November 13, 2014

Posted by AGORACOM-JC at 4:13 PM on Thursday, November 13th, 2014
Welcome to AGORACOM Q&A. We have invited Neah Power Systems Investors to ask questions which have been answered directly by management.With us today is Dr. Chris D’Couto President of Neah Power Systems, a developer of fuel cell power solutions using proprietary, award winning technology for the military, transportation, and portable electronic devices.

$50M+ Invested into Neah Power Systems

  • Intel Corporation, Novellus Systems, Four Tier 1 VCs, US Navy, NIST/ATP
  • award winning technology (Popular Science, MIT)

Hub On AGORACOM / Corporate Website / Watch Interview Now!
 

Health & Wellness Business Plan by Lexaria

Posted by AGORACOM-JC at 8:10 AM on Thursday, November 13th, 2014

 

KELOWNA, BC / November 13, 2014 / Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”).

Lexaria is in the midst of a major corporate transformation that began with our announcement on March 5, 2014, when we made a strategic entry into the Canadian medical marijuana sector. Since then we have added staff and consultants with expert knowledge of the sector, and our first licence submission to grow and sell medical marijuana in Canada is working its way through the Health Canada license application process.

Lexaria is increasingly focusing our valuable management time on a single corporate target: Lexaria wants to help people feel as healthy as they can. Our application to grow and sell marijuana under the MMPR regulations in Canada is part of that strategy; the PoViva Tea acquisition announced yesterday is another part of that same strategy; and additional planks in this strategy will be announced very soon.

While continuing to work towards LP (Licensed Producer) status in Canada, Lexaria believes firmly that our shareholders should not have to wait an indeterminate amount of time for clarity through the government licensing process. Instead, with PoViva Teas and other pending product announcements which we expect to be forthcoming shortly, Lexaria has aggressively entered the already legal CBD-enhanced marketplace.

Lexaria is examining opportunities in some of the most popular beverage and food categories in the USA and in the world.

The Alternative Health sector is large and growing. A long term Medical Expenditure Panel Survey was conducted from 2002 until 2008 with at least 29,370 subjects asked repeatedly if they had seen any kind of health care practitioner in the previous six months. The survey recorded whether the health care provider was a “complementary and alternative medicine care professional,” including “homeopathic, naturopathic, or herbalist.”

Between 5.3% and 5.8% of the survey group at any one time reported that they had seen a complementary or alternative medicine provider. Based on the US population of ~319,000,000, this suggests between 16.9 million and 18.5 million Americans are seeking an alternative health care professional at any given time.

Meanwhile the Centers for Disease Control and Prevention, in an April 2011 NCHS Data Brief, reported that more than 50% of the population uses dietary supplements of one kind or another. Detailed findings from that report included:

- Use of dietary supplements is common among the U.S. adult population. Over 40% used supplements in 1988–1994, and over one-half in 2003–2006.

- Multivitamins/multiminerals are the most commonly used dietary supplements, with approximately 40% of men and women reporting use during 2003–2006.

- Use of supplemental calcium increased from 28% during 1988–1994 to 61% during 2003–2006 among women aged 60 and over.

As we previously reported, more than 150 million Americans drink tea every day, amounting to some 79 billion servings of tea in America every year. Our launch of Poviva Tea Corp is meant to tap into this strong existing demand. PoViva has filed two patents pending to bind active CBD ingredients with a lipid, allowing for more efficient and comforting delivery of the CBD.

The legal medical marijuana market, in comparison, is much smaller measure both by number of patients as well as by total dollar volume.

Our goal is to begin producing cash flows from these initiatives as soon as possible; focused on the immediate opportunities in the CBD-sectors derived from already-legal hemp. CBD’s (Cannabidoil) have been found by many researchers to have antioxidant properties and Lexaria plans to use the patent pending process it has acquired with PoViva teas, to infuse CBD’s into a number of popular food and beverages.

Lexaria is planning to launch a line of premium products, always relying on our patent pending CBD-infusion process, to bring CBD’s into the mainstream. Because CBD’s do not have psychoactive properties we expect our products to appeal to the widest possible customer base. Initially we will focus our sales efforts across the continental USA.

Lexaria has commissioned a new website which is currently under development. When the site is in operation, customers will be able to place orders and interact with normal e-commerce capabilities. A national distribution center is also being contracted to ensure rapid and accurate fulfillment of all orders. A 1-800 ordering center will also be placed into operation.

Early in 2015 Lexaria will begin working on traditional retail sales channels and will work to continually develop those “bricks and mortar” sales methods. Also early in 2015 we hope to add our next CBD-based product line.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for opportunities that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana or alternative health businesses will provide any benefit to Lexaria. There is no assurance that PoViva Teas will be accepted into the marketplace or have any positive impact upon Lexaria Corp. There is no assurance that PoViva Teas will promote, assist, or maintain any beneficial human health conditions whatsoever.

The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Stria Lithium Announces Funding Commitment from the Government of Canada

Posted by AGORACOM-JC at 10:17 AM on Wednesday, November 12th, 2014

 

Innovation Funding Commitment to assist in the Company’s Development of Novel, Environmentally Sustainable Lithium Processing Technologies

 

OTTAWA, ONTARIO–(Nov. 12, 2014) - Stria Lithium Inc. (TSX VENTURE:SRA) (“Stria” or the “Company”) is pleased to announce that it has received a funding commitment of up to $137,700 from the Government of Canada through the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) in support of the Company’s continuing development of novel lithium processing technologies aimed at producing low-cost, very high purity lithium products.

Stria Lithium is advancing development of proprietary spodumene mineralization to lithium concentrate processing technologies capable of producing a low cost high-grade Li-metal, Li-carbonate and Li-hydroxide products.

On October 17, 2014, the Company announced it had completed a dense media separation study (“DMS”) with SGS Canada Ltd., demonstrating the mineralogical quality and viability for purification of spodumene mineralization from its 100% owned Pontax Lithium Project, Northern Quebec.

The mineralization will be used to feed Stria’s pilot plant located in Kingston, Ontario, scheduled for startup in early 2015.

Stria President and Chief Operating Officer Julien Davy said: “The federal government’s commitment of financial support bodes well for us in meeting our planned future production milestones, beginning with our pilot plant in Kingston. We are extremely grateful for NRC-IRAP’s business and technical advisory services, along with financial support, at this time in our process development.”

“Battery manufacturers are looking to the resource sector to find innovative solutions to lower production costs.

“Our decision to build our business on the development of new, proprietary processing technologies has attracted industry attention,” Mr. Davy added. “We believe our technologies hold the prospect of resolving not only cost and purity issues, but also, an industry imperative to do so on an environmentally sustainable basis.”

Stria’s aim is to license its potential technologies to electric vehicle and large-scale industrial energy storage battery manufacturers.

“Being able to ‘walk the talk,’ environmentally speaking,” Mr. Davy said, “is critical to our future success in the lithium industry.”

About Stria Lithium Inc.

Stria Lithium (TSX VENTURE:SRA) is a Mining Technology company that owns the Pontax spodumene lithium property in Northern Quebec and the Willcox brine lithium property in southeastern Arizona. As announced in January 2014, Stria is developing proprietary, in-house processing technologies for both projects with the purpose of reducing processing costs on an environmentally sustainable basis.

Stria’s technologies, based on recovering lithium metal directly from mineralization and from brine liquids, will be more efficient, will require fewer controls, less chemistry and require less energy from compact facilities designed to enable easy automation.

Forward Looking Statement – Disclaimer

This news release may contain forward-looking statements, being statements which are not historical facts, and discussions of future plans and objectives. There can be no assurance that such statements will prove accurate. Such statements are necessarily based upon a number of estimates and assumptions that are subject to numerous risks and uncertainties that could cause actual results and future events to differ materially from those anticipated or projected. Important factors that could cause actual results to differ materially from the Company’s expectations are in our documents filed from time to time with the TSX Venture Exchange and provincial securities regulators, most of which are available at www.sedar.com.

Stria Lithium Inc.
Mr. Julien Davy
President and COO
jdavy@strialithium.com

Lexaria Continues Transformation Into Alternative Health Sector

Posted by AGORACOM-JC at 8:07 AM on Wednesday, November 12th, 2014

 

Kelowna, British Columbia–(November 12, 2014) – Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) announces has entered an agreement and has begun a staged acquisition of a corporation and its expertise in delivering Cannabidiol (CBD)-infused products. This marks a major milestone for Lexaria as it is both our first foray into the United States based on a product derived from legal industrial hemp; and it is also Lexaria’s first step into the large alternative health and wellness sector.

Lexaria has initially acquired 51% of PoViva Corp, and can ultimately acquire up to 75% of the company through staged transactions. PoViva literally means “Taking in Life” PoViva uses a patent pending process to bind active CBD ingredients with a lipid, allowing for a more efficient and comforting delivery of the CBD than competing products that do not have the benefit of our patent-pending process.

PoViva owns two patents pending that govern the process used to infuse the CBD into food products, and both patents pending are part of the acquisition. An initial cash payment has been made to PoViva and Lexaria currently has sufficient cash resources to completely fund and launch the acquisition. Lexaria does not require any equity financing to complete the transaction.

Founder of PoViva, Ms. Marian Washington lends her extensive leadership and knowledge of athletic physiology to the company. Marion has Master’s Degree in Biodynamics and Administration and was awarded an honorary doctorate from West Chester State College. For thirty years, Marian served as head women’s basketball coach of prominent division one university. Ms. Washington has been received into multiple Halls of Fame, received prominent athletic leadership awards, and coached national and international teams, including coaching the 1996 Olympic Women’s Basketball Team to a gold medal.

Michelle Reillo, PhD, the co-founder of PoViva and will drive production and new products within PoViva as the Product and Research Manager. Michelle has a BSc in Nursing; a MS in Gerontology; and a PhD in Education. She has extensive experience with both Federal and private proposal development and submission and research projects, including CDC, NIH, NCI, NIDA, and AmFar. She is a former Clinical Director of Hyperbaric Medical Clinic. Michelle is the author of AIDS Under Pressure and pioneered retroviral research in hyperbaric medicine and HIV/AIDS. She is the author of many highly regarded research papers in the medical community.

Lexaria will strive to make its name synonymous with rejuvenation and healthy living. Lexaria believes that feelings of good health are a luxury to be enjoyed by all and will introduce products aimed to provide comfort and well-being. We are currently conducting our investigation of entering several popular food and drink sectors where our patent-pending cannabidiol delivery might prove particularly popular. Lexaria will announce further developments as our product mix becomes finalized.

To begin, we expect to launch PoViva Teas as our first CBD-infused product using our patent-pending processes as quickly as possible. According to the Tea Association of the USA Inc, Americans consumed over 79 billion servings of tea in 2012, its popularity far outstripping any alternative health sector. On any given day, over 150 million Americans consume tea, and 84% of all tea consumed is black tea.

Globally, tea is the most widely consumed beverage in the world after water, with over 3 billion servings of tea per day. As part of the current business agreement, Lexaria has acquired a 3-year exclusive right to the patent-pending process to infuse CBD’s into all global markets outside of the USA. We will investigate all global initiatives that build and promote the PoViva by Lexaria brand.

For example, the combined hot beverage markets of coffee and tea together, globally, is $69.77 Billion expected in 2015, according to a 2010 report by Basu Majumder A., Bera B. and Rajan A.

Lexaria is beginning construction of an e-commerce website that will allow for direct online sales of PoViva teas and other products across the United States. Other sales channels, both domestic and international will also be pursued and developed as rapidly as possible. Pre-orders for PoViva Tea by Lexaria will be accepted soon.

Tea naturally contains no sodium and virtually no calories but does contain flavonoids which are naturally occurring compounds thought to have antioxidant properties. PoViva Tea by Lexaria will include non-psychoactive CBD compounds through our patent pending process. Studies have shown that persons who drink 3 or more cups of black tea per day, have a reduced risk of heart disease and stroke. (1) Various studies have shown that drinking tea can reduce the incidence of contracting cancers such as prostate, rectal, colon, and squamous cell carcinoma. (2) Other research has found that consuming antioxidants, such as those that are found in tea and in CBD’s, may result in a 69% lower likelihood of developing Parkinson’s disease.(3)

According to the US Department of Health and Human Services Patent number 6,630,507, Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia. Nonpsychoactive cannabinoids, such as cannabidoil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention.”

Lexaria wishes to inform all stakeholders that it continues to pursue its Health Canada MMPR Licensed Producer status by way of its joint venture in Burlington Ontario with Enertopia Corp. Our goal of acquiring that license remains unchanged. However, in light of delays in the licensing process outside of our control, we continue to pursue opportunities to build shareholder value as functionally and rapidly as possible.

Lexaria will be announcing additional information on its product mix and business plan in the immediate future. Our goal is to begin producing cash flows from these initiatives as soon as possible; focused on the immediate opportunities in the CBD-sectors derived from already-legal hemp.

(1) Larsson SC, Virtamo J, Wolk A. Black tea consumption and risk of stroke in women and men. Ann Epidemiol. 2013 Mar; 23(3):157-60. (and Others)

(2) Su LJ, Arab L. Tea consumption and the reduced risk of colon cancer — results from a national prospective cohort study. Public Health Nutr. 2002 Jun; 5(3): 419-25. (and Others)

(3) Hu G, Bidel S, et al. Coffee and tea consumption and the risk of Parkinson’s disease. Mov Disord. 2007 Aug 21: [Epub ahead of print]

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:
Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana or alternative health businesses will provide any benefit to Lexaria. There is no assurance that PoViva Teas will be accepted into the marketplace or have any positive impact upon Lexaria Corp. There is no assurance that PoViva Teas will promote, assist, or maintain any beneficial human health conditions whatsoever.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Montreal’s first medical marijuana clinic opens doors

Posted by AGORACOM-JC at 3:17 PM on Tuesday, November 11th, 2014

Clinic serves as portal to legal access to medical cannabis

CBC News Posted: Nov 11, 2014 12:42 PM ET Last Updated: Nov 11, 2014 12:42 PM ET

Palliative care expert Dr. Michael Dworkind will serve as medical director of Santé Cannabis.Palliative care expert Dr. Michael Dworkind will serve as medical director of Santé Cannabis.

The first medical marijuana clinic in Quebec has opened its doors in Montreal.

The goal of Santé Cannabis is to evaluate patients for therapies using medical marijuana, said Adam Greenblatt, the clinics’s executive director.

“There’s about one million patients across Quebec who medicate with cannabis in some way or another,” Greenblatt told CBC’s Daybreak.

“But the large majority of them access their cannabis from illicit unregulated sources. So our goal really is to help facilitate access to legal sources of medical cannabis to eligible patients who meet certain qualifications.”

Santé CannabisSanté Cannabis is in Montreal’s Gay Village neighbourhood. (Kate McKenna/CBC)

The name, Santé Cannabis, is a play on the French term for the federal government department, Santé Canada, (Health Canada).

‘The purpose of our clinic is to serve as a portal to legal access to medical cannabis. We know that the demand is out there’- Adam Greenblatt, Santé Cannabis

Greenblatt has enlisted Dr. Michael Dworkind as the clinic’s medical director, while Dr. Marcia Gillman will serve his associate director.

Both are known for their work in palliative care at Montreal’s Jewish General Hospital.

Greenblatt plans to have five doctors working in the clinic by February 2015.

Patients who come to the clinic are asked to have a referral from their family doctor or treating physician.

He said the clinic follows the guidelines set out by Quebec’s Collège des Médecins on the prescription of medical cannabis.

$250 annual fee

Greenblatt says Quebec’s medical insurance system will cover the cost of the consultation by one of the clinic’s doctors.

After that, patients will have to pay a $250 annual fee for the uninsured services of the clinic.

Those services include help choosing a licensed cannabis producer and an appropriate marijuana strain for treatment, and help navigating through the medical marijuana system.

Greenblatt says Santé Cannabis is a private business, but the main motivation is not profit.

“The purpose of our clinic is to serve as a portal to legal access to medical cannabis,” said Greenblatt. “We know that the demand is out there.”

Source: http://www.cbc.ca/news/canada/montreal/montreal-s-first-medical-marijuana-clinic-opens-doors-1.2831175

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

CLIENT FEATURE: Robix (RZX: CSE) Revolutionary Oil Spill Clean Up Technology

Posted by AGORACOM-JC at 11:32 AM on Tuesday, November 11th, 2014

RZX: CSE

Highly Cost Effective – Clean Ocean Vessel

  • The COV’s rapid recovery rate and large on-board storage result in low per barrel recovery cost.
  • The COV’s simple design minimizes down time for repair and maintenance.
  • A two-man crew can be easily trained and the COV vessel can operate long hours without interruption
  • Construction of the first commercial Clean Ocean Vessel is progressing, with immanent launch anticipated

Design Versatility

  • COV’S can be scaled to meet various application requirements (sizes range from 10 Ft., 20 Ft., 40 Ft., 80 Ft., 100 Ft. (references to length of vessel
  • A standard 40-foot COV is 40 feet in length, 26 feet in width, and 12 feet in depth
  • The following page has a 3D visual description of a COV
  • Recently completed the engineering drawings for the Clean Ocean Vessel (COV) and ordered critical components to initiate construction on the COV

Recent Highlights

  • Creating a new business division, through a subsidiary entity, to enter into the marine industry.
  • Announced that Rick Carson, of Montreal, PQ, has agreed to join Robix as a Strategic Advisor.
  • Announced that it intends to enter into an agreement with Rayco Steel Inc., wherein Rayco shall work on completion of engineering construction drawings for the anticipated construction of the first Clean Ocean Vessel.

How the COV compares to the competition:

  • Rates of oil recovered and recovery-throughput efficiencies are noted as “oil rate of recovery” (ORR) and “recovery efficiency” (RE).
  • The water surface lifting force generated by the COV’s patented contra-rotating drums acts in a suction or pumping manner that increases the ORR compared to conventional skimmer systems and the RE of the COV is in the 90-97% range. This is competitive with best in class 21st century technology in terms of ORR and RE.
  • Further improvements to the ORR (in terms of gallons per minute) could easily catapult the COV to “top three” status, by increasing the surface area of the drums through design modifications without impairing the stability of the vessel which is inherent to the COV design.
  • When our competitors’ skimmer systems meet waves above 18 inches, they are forced to suspend service. The COV operates in rough sea conditions (as high as 8 feet waves), significantly out-performing its competitors, and stands in a class of its own.

Hub On AGORACOM / Corporate Website

 

Liberty Star Announces, New Wholly Owned Subsidiary Hay Mountain Super Project LLC, Potential Funder Site Visit and Agreement on North Pipes Super Project Lease Option

Posted by AGORACOM-JC at 9:39 AM on Monday, November 10th, 2014

TUCSON, Ariz.–Liberty Star Uranium & Metals Corp. (“Liberty Star” or the “Company”) (OTCQB: LBSR) is pleased to announce progress on various matters:

Liberty Star is moving forward to capitalize on the hard work it has expended over a number of years. We have a very positive outlook about our future as a result of these recent and ongoing developments.”

1. The Company has filed Articles of Organization with the Arizona Corporation Commission forming a wholly owned subsidiary named Hay Mountain Super Project LLC (“HMSP LLC” or the “Subsidiary”). The new Subsidiary is to manage Liberty Star’s premiere multi-target exploration property, the Hay Mountain Project, in southeast Arizona’s historic Tombstone mining district (Cochise County) for porphyry copper, gold, moly, silver, REEs and other associated metals. HMSP LLC will serve as the primary holding company for development of the potential ore bodies encompassed in the Hay Mountain area of interest covering some 42 square miles as identified by the extensive geological, geochemical and geophysical work, including ZTEM, performed to date. This is the first step toward establishing a corporate structure that will maximize operational and tax efficiencies, and enable the transfer of profits to Liberty Star Uranium & Metals Corp. where tax loss carry forwards can be used against positive cash flow, if any, from previous exploration expenses, while at the same time preserve the flexibility to engage joint enterprise investors in the independent development of multiple Hay Mountain targets as drilling verifies their candidacy as potential economically viable mining operations. Funding and management of the Hay Mountain Project and other Liberty Star surface studied and/or claimed lands totaling 42 square miles in the area will be administered through the Subsidiary.

Comments Jim Briscoe, Liberty Star’s CEO and Chief Geologist: “This progress toward assembling the corporate machinery forming the basis for attracting and engaging qualified joint enterprise investors to participate in developing the potentially extraordinary mineral content of the Hay Mountain properties, as documented in prior Liberty Star press releases, is a milestone event in Liberty Star’s growth. I am pleased and excited with our establishing this threshold into the next phase of revealing Hay Mountain’s potential as a world class mining district.”

2. Liberty Star announces that the Company’s CEO/Chief Geologist Jim Briscoe and Director (mining engineer-attorney) Brett Gross will host a three day visit including a two day site visit to the Hay Mountain Project area for a potential funder from the Arabian Peninsula who has signed a non-disclosure agreement. This trip is tentatively planned before Thanksgiving, dependent only on US entry visa and travel arrangements. Accompanying the two parties will be an independent geologist/porphyry copper expert hired by the guest as well as an arms- length Registered Professional Geologist (RPG) who is experienced in a particular (classic) porphyry copper skarn deposit in the SW USA, participated in intensive postgraduate study of porphyry copper skarn deposits and has used vegetation geochemistry like that used by Liberty Star at Hay Mountain (and supervised by our Technical Board Member – and Geochemist, Shea Clark Smith) and is familiar with distal halos of the Hay Mountain type skarn mineralization. In addition to the Hay Mountain Project area, the visit will include ASARCO’s Mission Mine and the Bisbee mining district, both of which are corollaries to Hay Mountain (exposed rather than covered). The tour will also include two other similar porphyry copper drilling projects and one small porphyry copper production facility with exploration potential. During the trip in this mineral rich area there will also be viewings of dormant porphyry copper, gold and silver mines, including Tombstone itself. These sites, all within a 60 mile radius of the Hay Mountain Project, will demonstrate and solidify the similarity of other large porphyry copper operations to the as yet undrilled Hay Mountain which lies hidden beneath shallow cover. The trip will take two days and a 3rd day is reserved for a second review of the technical details of the Hay Mountain data, and discussion of Joint Venture parameters.

3. The final Archaeological Assessment document has been finished by the Company’s contractor Antigua Archaeology LLC, and was submitted to the Arizona State Land Department (ASLD) for their final approval on November 5, 2014. No significant archaeological material was found and the report recommends approval of our proposal as written. According to the ASLD, response time is dependent on the length of the queue but should take place in 30 to 90 days. This is the final step in the long approval process. When ASLD final approval is received, Liberty Star is ready to drill as soon as funding is in place.

4. The Company is getting more expressions of interest every day and expects to make additional presentation trips as described in number 2 until Phase 1 financing is attained. Currently there are three seemingly qualified entities that have expressed strong interest.

5. For more than a year, lengthy negotiations have been ongoing with Genesis Group International Inc. to option the North Pipes Super Project (uranium) which lies just south of the Utah border. Genesis has developed a unique, proprietary type of equipment and process to mining breccia pipe type vertical mineral ore bodies. The Company has executed a letter agreement subject to formal legal drafting. This will involve an exchange of Liberty Star’s real property and intellectual property pertaining to the North Pipes/ Arizona Strip properties. In exchange Liberty Star will receive a significant monthly payment toward retirement of its expenditures on the North Pipes Project. It will also receive a gross royalty (NSR – Net Smelter [mill return] Royalty type, which is common in the mineral industry) on production that would result from all metal commodities coming from any mining of the pipes. It is expected that this could commence in about six months from now, at which time full financial and state support will become available. Profitable operation of the breccia pipes even at current low uranium prices is anticipated from this rapid and unique mining equipment and approach.

Concludes Briscoe: “Liberty Star is moving forward to capitalize on the hard work it has expended over a number of years. We have a very positive outlook about our future as a result of these recent and ongoing developments.”

“James A. Briscoe” James A. Briscoe, Professional Geologist, AZ CA
CEO/Chief Geologist
Liberty Star Uranium & Metals Corp.

Forward Looking Statements

Statements in this news release that are not historical are forward looking statements. Forward-looking statements in this news release include that the Hay Mountain Project is ready for drilling once we can obtain ASLD approval and financing for phase 1 drilling; that our project is prospective for many minerals; that we will be able to attract a partner/investor for the North Pipes uranium program; that our project will be profitable; and that we can come to a final agreement with Genesis. Factors which may delay or prevent these forward-looking statements from being realized include: the failure of our proposals or our Archeological Assessment to be accepted; we may not be able to raise sufficient funds to complete our intended exploration, keep our properties or carry on operations; and an inability to continue development due to weather, logistical problems, labor or equipment problems or hazards even if funds are available. Even if our proposals are accepted, we may not be able to carry out project development as contemplated. Despite encouraging data there may be no commercially exploitable mineralization on our properties. Readers should refer to the risk disclosures in the Company’s last 10-K and the Company’s other periodic reports filed from time to time with the Securities and Exchange Commission.

View: Introduction to Hay Mountain Project Presentation

Contacts

Agoracom Investor Relations
lbsr@agoracom.com
http://agoracom.com/ir/libertystar
or
Liberty Star Uranium & Metals Corp.
Tracy Myers, 520-425-1433
Investor Relations
info@LibertyStarUranium.com
Follow Liberty Star Uranium & Metals Corp. on Facebook , LinkedIn & Twitter@LibertyStarLBSR